BIOMARIN PHARMACEUTICAL INC (BMRN)

US09061G1013 - Common Stock

90.1  -1.14 (-1.25%)

After market: 90.1 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
2.42B2.10B1.85B1.86B1.70B
Cost Of Goods
514.85M483.70M470.50M524.30M359.50M
Gross Profit
1.90B1.61B1.38B1.34B1.34B
Operating Expenses
1.75B1.55B1.46B1.43B1.46B
Research and Development
746.77M649.60M628.80M628.10M715.00M
Selling, General, and Administrative Expenses
937.29M831.00M760.90M737.80M675.70M
Operating Income
158.10M64.60M-83.80M-96.40M-120.20M
Interest Income/Expense
41.00M2.10M-3.40M-12.60M-6.60M
Other Income/Expense
-10.54M-2.10M11.80M7.10M6.90M
Non Recurring Items
0.0085.00M0.0059.50M25.00M
Income Before Taxes
188.56M149.60M-75.40M-42.30M-94.80M
Income Tax
20.92M8.00M-7.40M-46.90M-71.00M
Net Income
167.65M141.60M-64.10M859.10M-23.80M
EBITDA
262.48M166.60M24.20M8.80M-14.90M
 
Per Share Data
EPS Diluted Total Ops
0.880.75-0.374.48-0.13
Non GAAP EPS
1.260.29-0.364.55-0.15
 
Statistics
Gross Profit Margin
78.72%76.93%74.52%71.82%78.91%
Profit Margin
6.93%6.76%-3.47%46.18%-1.40%
Operating Profit Margin
6.54%3.08%-4.54%-5.18%-7.05%

All data in USD

Charts